一名帕金森病患者出现与齐拉西酮相关的神经阻滞剂恶性综合征：一项诊断挑战。

Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.

作者信息

Gray Nicola S

机构信息

Department of Psychiatry, Allegheny General Hospital, Four Allegheny Center, 8th Floor, Pittsburgh, PA 15212-4772, USA.

出版信息

Hum Psychopharmacol. 2004 Apr;19(3):205-7. doi: 10.1002/hup.578.

DOI:10.1002/hup.578

PMID:15079855

Abstract

A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed.

摘要

本文介绍了一例帕金森病（PD）患者发生抗精神病药恶性综合征（NMS）的病例。该综合征由非典型抗精神病药物齐拉西酮诱发。文中讨论了在患有潜在帕金森症状的患者中识别NMS的挑战，因为可能会出现明显的症状重叠。